Literature DB >> 18412330

Regioselectivity prediction of CYP1A2-mediated phase I metabolism.

Jihoon Jung1, Nam Doo Kim, Su Yeon Kim, Inhee Choi, Kwang-Hwi Cho, Won Seok Oh, Doo Nam Kim, Kyoung Tai No.   

Abstract

A kinetic, reactivity-binding model has been proposed to predict the regioselectivity of substrates meditated by the CYP1A2 enzyme, which is responsible for the metabolism of planar-conjugated compounds such as caffeine. This model consists of a docking simulation for binding energy and a semiempirical molecular orbital calculation for activation energy. Possible binding modes of CYP1A2 substrates were first examined using automated docking based on the crystal structure of CYP1A2, and binding energy was calculated. Then, activation energies for CYP1A2-mediated metabolism reactions were calculated using the semiempirical molecular orbital calculation, AM1. Finally, the metabolic probability obtained from two energy terms, binding and activation energies, was used for predicting the most probable metabolic site. This model predicted 8 out of 12 substrates accurately as the primary preferred site among all possible metabolic sites, and the other four substrates were predicted into the secondary preferred site. This method can be applied for qualitative prediction of drug metabolism mediated by CYP1A2 and other CYP450 family enzymes, helping to develop drugs efficiently.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18412330     DOI: 10.1021/ci800001m

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  7 in total

1.  Predicting drug metabolism by CYP1A1, CYP1A2, and CYP1B1: insights from MetaSite, molecular docking and quantum chemical calculations.

Authors:  Preeti Pragyan; Siddharth S Kesharwani; Prajwal P Nandekar; Vijay Rathod; Abhay T Sangamwar
Journal:  Mol Divers       Date:  2014-07-16       Impact factor: 2.943

2.  SMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism.

Authors:  Patrik Rydberg; David E Gloriam; Jed Zaretzki; Curt Breneman; Lars Olsen
Journal:  ACS Med Chem Lett       Date:  2010-03-15       Impact factor: 4.345

3.  Potentially increasing the metabolic stability of drug candidates via computational site of metabolism prediction by CYP2C9: The utility of incorporating protein flexibility via an ensemble of structures.

Authors:  Matthew L Danielson; Prashant V Desai; Michael A Mohutsky; Steven A Wrighton; Markus A Lill
Journal:  Eur J Med Chem       Date:  2011-06-23       Impact factor: 6.514

Review 4.  Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms.

Authors:  Johannes Kirchmair; Mark J Williamson; Jonathan D Tyzack; Lu Tan; Peter J Bond; Andreas Bender; Robert C Glen
Journal:  J Chem Inf Model       Date:  2012-02-17       Impact factor: 4.956

5.  A Mechanism-Based Model for the Prediction of the Metabolic Sites of Steroids Mediated by Cytochrome P450 3A4.

Authors:  Zi-Ru Dai; Chun-Zhi Ai; Guang-Bo Ge; Yu-Qi He; Jing-Jing Wu; Jia-Yue Wang; Hui-Zi Man; Yan Jia; Ling Yang
Journal:  Int J Mol Sci       Date:  2015-06-30       Impact factor: 5.923

6.  A practical strategy to design and develop an isoform-specific fluorescent probe for a target enzyme: CYP1A1 as a case study.

Authors:  Zi-Ru Dai; Lei Feng; Qiang Jin; Hailing Cheng; Yan Li; Jing Ning; Yang Yu; Guang-Bo Ge; Jing-Nan Cui; Ling Yang
Journal:  Chem Sci       Date:  2016-12-19       Impact factor: 9.825

Review 7.  Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors.

Authors:  Zbigniew Dutkiewicz; Renata Mikstacka
Journal:  Bioinorg Chem Appl       Date:  2018-07-25       Impact factor: 7.778

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.